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The maintenance of membrane lipid composition within strict limits is critical to maintain opti-
mum cellular function. The biophysical properties of the membrane can be inﬂuenced among other
factors by the saturation/unsaturation of the phospholipid fatty acyl chain. The rate-limiting
enzyme in unsaturated fatty acid biosynthesis is the desaturase enzyme which in turn is regulated
by the lipid transcription factor sterol regulatory element binding protein (SREBP1). In this review,
we collect some evidence suggesting SREBP1 network as an important allostatic regulator necessary
to maintain the pool of unsaturated fatty acid lipid species that can be incorporated into biological
membranes.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction of the concept of SREBP/Insigs as allostatic
mediators
In this review we explore the concept that the sterol regulatory
element binding protein 1 (SREBP1) network may be an allostatic
node contributing to lipid membrane composition quality control
mechanisms. As SREBP1 is central in the control of a variety of lipid
biosynthetic pathways (in particular lipid desaturation and
phospholipid biosynthesis), our view is that SREBP1 may be an
important allostatic mediator that induces adaptive responses to
dietary/environmental stresses potentially resulting in lipid per-
turbations to maintain optimal membrane lipid composition and
ensure cell survival and function (Fig. 1). The concept of allostasis
was introduced by Sterling and Eye in 1993 to capture the idea of
‘‘maintenance of stability through change”. From this concept it
can be implied that biological systems are ﬂexible, with set points,
internal controls and adaptive responses that allow them to main-chemical Societies. Published by E
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hotmail.com (R.M. Hagen),tain key fundamental biological parameters (e.g. glucose, blood
pressure, biological membrane lipid composition and biophysical
properties) within strict physiological homeostatic limits [1]. These
allostatic responses can require energy and can themselves be a
cause of stress. Maintenance of these allostatic adaptations im-
poses different degrees of stress to the components of a system
that on their own may have different degrees of vulnerability. Fol-
lowing this, allostatic adaptations can occasionally cause inappro-
priate activation of alternative paths that on their own can become
toxic causing collateral damage and disease. We think that the con-
cept of allostasis can be applied to the mechanisms controlling
membrane lipid composition quality and suggest the possibility
that the SREBP1/Insig could be an important node of this allostatic
responses.
Lipids are as fundamental to life as are DNA and proteins. Unlike
other classes of biomolecules such as proteins and DNA, the struc-
ture of lipids varies tremendously. This is in our opinion probably
the reason why studies focused in lipid biochemistry are well be-
hind compared to studies involving nucleic acids or proteins. In
fact the eukaryotic cell uses approximately 5% of its genes to gen-
erate thousands of different lipid species [2] suggesting there has
been evolutionary pressure to be able to synthesise a large number
of diverse lipid species. Lipids are involved in a wide array of pro-
cesses from compartmentalisation of the cell with membranes to
provide efﬁcient energy storage and speciﬁc substrates for cell sig-
nalling. The importance of lipids is outlined by the large number of
human pathologies that in one way or another have been linked to
altered lipid and membrane properties, including cardiovascular
diseases, diabetes, obesity, inﬂammation, autoimmune diseases,
neurological diseases and cancer [3 and references within]. Thuslsevier B.V. All rights reserved.
Fig. 1. A cartoon interpretation of how SREBP1 can maintain membrane composition through control of fatty acid desaturation and phosphatidylcholine (PC) biosynthesis. A
decrease in membrane ﬂuidity may be sensed by SREBP/Insig complex. A reduction in Insig-1 facilitates SREBP cleavage and increases SREBP activation. SREBP upregulates
SCD1, FAS, lipase action and PC biosynthesis resulting in increased biosynthesis of monounsaturated fatty acids and PC which can increase membrane ﬂuidity. If the
membrane becomes too ﬂuid, SREBP is no longer activated (possibly through an increase of the SREBP anchor Insig-1 and desaturase and PC biosynthesis) and membrane
ﬂuidity is reduced.
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pid composition affects the physiological function of the cell is
important if we are going to determine how lipid alterations inﬂu-
ence cell signalling in pathologies where lipid changes have been
extensively reported, such as type 2 diabetes or atherosclerosis.
One aspect of which alterations in lipid composition can have
profound effects is on the biophysical properties of the biological
membrane. Biological membranes enclose cytoplasmic mem-
branes as well as organelles’ membranes acting as a permeability
barrier, separating out different compartments and producing opti-
mum environmental conditions for biological processes within the
cell. The cell membrane is a highly dynamic structure that needs to
be able to grow in size during growth and cell division, and main-
tain continual turnover and renewal of membrane components un-
der resting conditions [4]. The cell membranes are composed
predominantly of a bilayer of phospholipids in which sphingolipids
and sterols are also present. However, the membrane bilayer is not
homogeneous in nature. Specialised structures such as ‘‘lipid rafts”
or lipid microdomains characteristically enriched in cholesterol
and sphingomyelin serve as communication hubs for signal trans-
duction pathways where receptors cluster to coordinate speciﬁc
signalling events and cellular functions. The membranes are
composed of diverse glycerophospholipids species consisting of
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phos-
phatidylserine (PS) and phosphatidylinositol (PI). They all have a
common structure including a polar phosphate containing the
head group and two hydrophobic hydrocarbon chains derived from
fatty acids. The fatty acid chains are numbered sn-1 and sn-2 and
are usually between 14 and 24 carbons in length, whilst one chain
is usually unsaturated (usually at the sn-2 position).
Fatty acid chains in phospholipids change in response to vary-
ing environmental stresses, such as temperature. The relationship
between temperature and membrane ﬂuidity (homeoviscous
adaptation) has been extensively studied in bacteria, but many ofits characteristics can be applied to plants and animals [5]. As
the temperature increases there is a decrease in unsaturated fatty
acyl chains and an increase in the average length of fatty acid
chains, allowing the membrane to become more rigid. In mamma-
lians, sterols are an additional component that is important in reg-
ulating membrane ﬂuidity. In fact increased sterol concentrations
within a membrane results in increased rigidity and a reduction
in ﬂuidity.
The effect of fatty acid unsaturation on the membrane ﬂuidity is
probably one of the best characterised phenomenons, which has
been demonstrated in animals, ﬁsh, fungi, plants, bacteria and cya-
nobacteria [6]. In fact the ratio between saturated and monounsat-
urated fatty acids (MUFA) chains of the phospholipids can directly
inﬂuence the physical properties of cell membranes. An increase in
the saturated fatty acid content results in decreased membrane ﬂu-
idity, as the phospholipids are able to pack densely together. The
importance of this function is revealed by the fact that the en-
zymes involved in the desaturation of lipids, so called desaturases
have been evolutionally conserved [7]. However, it is not only the
fatty acyl chain unsaturation characteristics that can affect mem-
brane function. Among other factors, the head group alteration of
phospholipids inﬂuence membrane behaviour. Choline is a bulky
headgroup and thus PC has a cylindrical molecular geometry [8].
In contrast, ethanolamine is a smaller headgroup and thus PE as-
sumes a conical molecular geometry. The smaller headgroup of
PE allows tighter packing of the phospholipids and thus, when as
the abundance of PE versus PC increases there is a reduction in
membrane ﬂuidity.
A combination of the degree and orientation of double bonds
within the fatty acid hydrocarbon chain, phospholipid head groups
and length of chains has led to the existence of more than 1000
different lipid species in a cell [2]. This diversity in lipid species
allows optimising the lipid composition of membranes to fulﬁll
speciﬁc functions. Importantly, the lipid composition ofmembranes
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found tohave aunique lipid composition allowingoptimal function-
ality. For example, the plasmamembrane contains a high concentra-
tion of sterols and sphingolipids compared with the endoplasmic
reticulum (ER)with the consequence that the ERmembrane ismore
ﬂuid [8]. Mitochondria, the Golgi apparatus, peroxisomes, and even
the lipid droplets also have distinct lipid composition,which confers
the correct biophysical properties to each organelle and contribute
tomaintain the viability of the cell. Depending on their composition,
these biomembranes play an important role in regulatingmany cel-
lular functions, in addition to the mere compartmentalisation, such
as signal transduction, cell adhesion, lipid trafﬁcking, ion channel
function, receptor mobility/interaction and viral/bacterial entry
[9,10]. Thus, the diverse lipid repertoire provides the advantage of
optimising membrane composition to its specialised functions.
However, this raises several problems: (a) What are the mecha-
nisms of quality control over membrane lipid composition? (b)
How speciﬁc are these mechanisms to sense selective lipid defects?
(c) How selective are the allostatic responses in ﬁxing selective
defects?
2. Where do the unsaturated fatty acids for incorporation into
membranes come from?
Hydrocarbon chains of fatty acids can either be classed as satu-
rated, MUFA or polyunsaturated fatty acids (PUFA), depending on
the number of double bonds present. Cells have the capacity to
synthesise fatty acids de novo via the enzymes acetyl coal carbox-
ylase (ACC) and fatty acid synthase (FAS), resulting in the genera-
tion of palmitic fatty acid (16:0) through a series of cyclic
reactions (1. condensation, 2. ketoreduction, 3. dehydration and
4. enoyl reduction). Fatty acids derived from the diet and from de
novo lipogenesis can be further elongated and double bonds added
via elongases and desaturases respectively contribute to generate a
variety of lipid species. Later on, through the actions of lipid
remodelling enzymes such as phospholipases and lysophospho-
lipid acyltransferases (LPLATs) a speciﬁc membrane lipid composi-
tion can be maintained. However, a remaining challenge is to
determine how these mechanisms can be regulated to match the
speciﬁc needs of the membranes. In our opinion the most efﬁcient
way to solve this biological problem would be via double levels of
regulation: (a) A long loop based on adaptive transcriptional re-
sponses aiming at producing a substrate pool and (b) A short loop
able to select/produce the speciﬁc lipid species from the pool to
provide the speciﬁc needs. As a proof of concept of the existence
of allostatic mechanisms contributing to the membrane quality
control in this review, we will focus speciﬁcally on the ﬁrst level
of control through the action and clinical relevance of transcrip-
tional networks controlling the level of unsaturation (for further
information on elongases and elongation of lipids please see re-
views by [11,12]).
The regulation of desaturases will ultimately affect lipid compo-
sition of the cell, as their activity will determine the ratio of unsat-
urated to saturated lipids within the cell. In mammals, there are
two classes of desaturases. Stearoyl-CoA desaturase (SCD) is a D-
9 desaturase ER bound membrane rate-limiting enzyme involved
in the conversion of saturated fatty acids to MUFA. SCD is associ-
ated with nicotinamide adenine dinucleotide phosphate (NADPH),
cytochrome b5 reductase, and cytochrome b5 and in the presence
of molecular oxygen introduces a single double bond (between car-
bons 9 and 10), into saturated fatty acyl-CoAs [12]. The other class
of desaturases is comprised ofD-5 (FADS1) andD-6 (FADS2) desat-
urases that are responsible for the production of PUFAs or HUFAs
(highly unsaturated fatty acids) such as arachidonic acid (AA)and EPA which are the precursors for omega-3 and omega-6 fatty
acids (for review see [12]).
3. Why is it so important to control the balance of unsaturated
versus saturated fatty acids? Insights from model organisms
lacking desaturase activity
The importance of the desaturase programme and the resulting
physiological complications arising from unsaturated fatty acid
deﬁciency has been demonstrated using mutant model organisms
such as Caenorhabditis elegans (C. elegans) and murine models. For
instance C. elegansmutants lacking crucial components of the fatty
acid desaturation pathway demonstrate the vital function that
unsaturated fatty acids play in overall physiology of organisms.
C. elegans mutants that lack D-6 desaturase activity have delayed
growth and altered behaviour. This is likely to be a direct result
of defects in the synaptic vesicle recycling and thus impairment
in neurotransmission. They also exhibit neuromuscular defects,
cuticle abnormalities, reduced innate immune response, impaired
sensory signalling, altered biological rhythms and reduced fertility
[13]. Fertility problems are more evident in the D-6 desaturase
mutants at low temperatures where embryogenesis is impaired,
most likely through impairment in oogenesis. At higher tempera-
tures reproduction success is higher suggesting that it is a defective
adaptation to low temperatures that is compromised in these mu-
tants. An inability to adapt to low temperatures is not surprising as
it has been well documented that in poikilotherms, bacteria and
plants in response to lower temperatures there is an induction in
desaturase activity, suggesting a direct link between membrane
ﬂuidity and desaturase activation [6].
In higher organisms such as mice, the role and function of the
desaturases have also been extensively investigated. Mice lacking
D-9 desaturase activity (SCD1 KO) have reduced body adiposity,
increased insulin sensitivity and are resistant to diet induced
obesity [14]. This alteration in body fat composition is a result
of increased energy expenditure that appears to be an adaptive
activation in response to disruption of the skin epidermal lipid
barrier in these mice [15]. SCD1 KO mice have a reduction in li-
pid biosynthetic genes corresponding with decreased triglyceride
accumulation, a reduction in cholesterol/wax esters and seba-
ceous gland hyperplasia [16]. These mice also suffer from ‘‘dry
eye syndrome” as a result of reduced sebaceous lipids. With
these alterations in the lipids of the skin and retinal barriers it
is not surprising that as observed with the C. elegans mutants,
mice which that have lack of SCD1 only in the skin have a re-
duced capacity to adapt to low temperatures and are cold intol-
erant [16]. Mice lacking D-6 desaturase activity (FADS2) are
relatively normal phenotypically but again, similar to the C. ele-
gans mutants have fertility problems with a large proportion of
the mutants being sterile. In humans, a mutation related to
impairment in D-6 desaturase activity has been associated with
impairment in growth and skin disease [17].
All in all, the data from various organisms highlight at least
three main physiological abnormalities that correspond with a
reduction in lipid unsaturation: (1) Neurological function, possibly
through altered synaptic transmission between neurons and prop-
agation of electrical signals. (2) Alterations in the skin barrier. (3)
Inability to adapt to low temperatures. Composition of the bilayer
may affect electrical properties and the properties of proteins and
receptors embedded in the membrane. The association of a broad
range of diseases with dysregulation of lipid metabolism and
membrane composition underlines the important need for tight
regulation of lipid composition of the cell and biological
membranes.
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Fatty acids are activated by acyl CoA synthetases (ACS) yielding
fatty acyl-CoA molecules that are used in the biosynthesis of phos-
phatidic acid (PA) and subsequently in phospholipid biosynthesis.
ACS provide a ﬁrst level of regulation since they seem to have a
certain degree of fatty acid substrate speciﬁcity and contribute to
sort speciﬁc fatty acids to speciﬁc compartments and functions
[52]. As mentioned previously, the nature of the fatty acids incor-
porated during the biosynthetic process is an important determi-
nant of the biophysical properties of the membrane. The glycerol
backbones of phospholipids are generated from the catabolism of
glucose and pyruvate (glyceroneogenesis). The precursor molecule
glycerol-3-phosphate is acylated and incorporates the activated
fatty acids via the action of glycerol 3-phosphate acyltransferase
(GPAT) producing 1-acyl-glycerol 3-phosphate (lysophosphatidic
acid, LPA). LPA is subsequently converted to PA via the enzyme
acylglycerol 3-phosphate acyltransferase (AGPAT). Depending on
substrate needs PA can either be dephosphorylated to generate a
diacylglycerol molecule (DAG) or is converted to cytidine 5-
diphospho-diacylglycerol (CDP-DAG) to be used in the generation
of phosphoinositides, phosphoglycerol and cardiolipin.
DAG molecules can then be further utilised to generate triacyl-
glycerol (TAG),PCorPEspecies.DAGproduction fromPA is catalyzed
by the enzyme phosphatidate phosphatise 1 (PAP1/Lipin). PAP1
transcription is upregulated by fatty acids mediated by activation
of PPARa and potentially through PPARc [25]. Upon activation (by
fatty acids/insulin) PAP1 translocates from the cytosol to the ER
where it utilises PA to generate DAG, the precursor of TAG and phos-
pholipids. TheﬂuxofDAG towards either TAG synthesis or phospho-
lipid synthesis is largely inﬂuenced by the activity of the
CTP:phosphocholine cytidylyltransferase (CCT) and the require-
ment for phospholipids. There seems to be in place tightly regulated
systems that allows prioritisation of lipid species into speciﬁc bio-
synthetic pathways. In fact when mechanisms of quality control
sense that phospholipid synthesis requirements are low,DAG is con-
verted into TAGby the enzymediacylglycerol-acyl CoAacyltransfer-
ase (DGAT) and TAG is stored as lipid bodies/dropletswithin the cell.
PC is the primary phospholipid of eukaryotic cellular mem-
branes. PC can be synthesised either by the via the CDP-choline
pathway dependent on CCT as the rate-limiting enzyme. The pro-
duction of PC by the CDP-choline pathway takes place through
three stages. First, there is the phosphorylation of intracellular cho-
line (mediated by choline kinase), followed by conversion of phos-
phocholine to CDP-choline (mediated by CCT), and ﬁnally a
phosphocholine moiety is transferred from CDP-choline to DAG
thus forming PC [mediated by CDP-Choline: 1,2-diacylglycerol
cholinephosphotransferase (CPT)]. CCT is reversibly phosphory-
lated at multiple serine residues (via casein kinase II, cdc2 kinase,
cAMP kinase and PKC) and is activated by associating directly with
the cell membrane. It seems that alterations on the membrane
structure resulting in changes in membrane bilayer curvature in-
duce elastic stress that governs the degree of CCT association with
membranes and its activity [18].
The pool of phospholipids does not only depend on transcrip-
tionally driven de novo biosynthesis. Cell membranes undergo
continual remodelling with phospholipids being continually syn-
thesised and hydrolyzed [4]. This second loop of regulation allows
acute adjustment of membrane composition in response to envi-
ronmental demands. Globally considered remodelling of phospho-
lipids is mediated by three different steps: (1). Deacylation (by
phospholipases). (2). Fatty acid synthesis (by FAS). (3). Reacylation
(by acyltransferases). Phospholipases are a group of enzymes able
to hydrolyze phospholipids and contribute to the biosynthesis of
many intracellular lipid messengers. Products derived from phos-pholipids by phospholipases include DAG, inositol triphosphate,
arachidonic acid (AA), platelet activating factor and prostaglandins.
LPLATs are responsible for the turnover of the fatty acid hydrocar-
bon at the sn-2 position of phospholipids resulting in a diverse ar-
ray of phospholipids independent of de novo synthesis. LPLATs
transfer activated fatty acids (acyl-CoA esters produced via acyl-
CoA synthetase) to lysophospholipids and control the phospholipid
levels containing lipid-mediated precursors such as arachidonic
acid (for a more detailed review refer to [19]).
In summary, there are a number of key steps as part of a double
level of control in the generation of speciﬁc phospholipids to be
incorporated into biomembranes. Through a concerted effort of
desaturases, elongases, genes involved in phospholipid biosynthe-
sis (long loop) as well as phospholipases and LPLATs (short loop) a
diverse array of lipids is generated in order to provide an efﬁcient
membrane composition. However the efﬁciency of these loops de-
pends on having proper regulatory allostatic membrane quality
control mechanisms.
5. Is there any evidence that human metabolic pathologies are
related to altered unsaturated lipid composition?
As aforementioned, the maintenance of an appropriate mem-
brane lipid composition appears to be crucial since differences in
the ratio between speciﬁc lipids (e.g. saturated/PUFA) can result
in differences in membrane ﬂuidity, topology of attached proteins,
activity of membrane-bound enzymes (e.g. GTPases), degree of
exposure of surface proteins, lateral mobility of receptors (e.g.
insulin receptor) and activation of speciﬁc signalling pathways
(e.g. insulin signalling). In fact the subtle alterations in lipid metab-
olism and phospholipid composition (in particular levels of PUFAs)
can have profound clinical effects. For instance, alterations in the
fatty acid composition of membrane phospholipids have been
linked to obesity and insulin resistance [20]. The effects of fatty
acids on energy balance can also occur at the level of the metabolic
rate. This is shown in rats fed a diet rich in saturated fatty acid (di-
rectly associated with decreased membrane ﬂuidity) which had
decreased beta-adrenergic receptor binding afﬁnity in adipose tis-
sue and brain, leading to a reduction in sympathetic activity and
lipolysis in brown adipose tissue and by hence, a reduction in diet
induced thermogenic capacity [21]. Whether the alterations in ﬂu-
idity are directly due to alterations in fatty acid desaturase/elong-
ase/LPLAT activity or redistribution of other membrane lipids has
yet to be determined. Diseases such as diabetes is associated with
decreased red blood cell membrane ﬂuidity as a result of increased
cholesterol content, decreased phospholipids and decreased pro-
tein levels [22]. Altered phospholipid composition has also been
linked to insulin resistance in skeletal muscle in human and rodent
models [23]. In the same line, it has already been established that
lipid microdomains are critical for proper compartmentalisation of
insulin receptors and the mediation of downstream signalling [24].
Conversely, increased PUFA concentration (and presumably in-
creased ﬂuidity of membrane) seems to improve insulin action.
The distribution of phospholipid classes in the adipocyte mem-
brane has also been associated with insulin resistance. In human
obese females, the amount of sphingomyelin and cholesterol con-
tent within the adipocyte membrane negatively correlated with
insulin sensitivity suggesting that these changes may affect struc-
tural properties and subsequently affecting insulin action [22].
6. How dysregulated unsaturated fatty acids may inﬂuence
adipose tissue expansion and obesity complications?
The need to maintain a proper level of fatty acid desaturation is
fundamental to prevent the deleterious effects of the accumulation
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fatty acids). This surplus of saturated fatty acids has been associ-
ated with lipid induced toxic effects such as the generation of reac-
tive oxygen species (ROS), de novo ceramide synthesis, and
activation of the apoptotic cascade [25], ultimately leading to insu-
lin resistance and impairment of mitochondrial structure/function.
MUFA such as oleic acids are preferentially incorporated into tri-
glycerides and in doing so they may have a less lipotoxic effect
than saturated fatty acids as the TAG pool may help to buffer the
saturated fatty acids [26,27]. Thus, the improved ability to store ex-
cess lipids should be considered as a crucial buffering process
sequestering away potentially toxic fatty acids to ensure the opti-
mum functionality of the cell. Illustrating this concept, ablation of
the key triglyceride biosynthetic enzyme, DGAT-1 results in im-
paired triglyceride synthesis and DAG accumulation promoting
the development of lipotoxicity in cells.
The accumulation of TAG stores in the form of a neutral lipid
droplet provides a reservoir of lipids for maintenance of cellular li-
pid homeostasis, energy storage and production of signalling lipids
under stress conditions such as food deprivation. Adipose tissue is
a vital organ as it is able to provide safe storage capacity of energy
and indirectly prevents ectopic energy storage. Under conditions of
overnutrition and excess of inﬂux of fatty acids into peripheral or-
gans such as liver, skeletal muscle and pancreas, accumulation of
excessive lipids can lead to metabolic complications, such as insu-
lin resistance and inﬂammation [28]. Therefore, storage and
expandability capacity of the adipocyte are important for the par-
tition and storage of fatty acids away from vulnerable tissues.
The lipid droplet is a subcellular compartmentwith a speciﬁc and
unique lipid and protein composition distinct to other cellular
organelles [29]. The lipid droplet is composed of a monolayer of
phospholipids and hydrophobic proteins surrounding a hydropho-
bic core of neutral lipid species such as TAGs and cholesterol esters.
Under conditions where fatty acids are needed, lipids are mobilised
fromthe lipiddropletby lipases. There is evidence that lipasesare re-
cruited and interact directly with the lipid droplet membrane in re-
sponse to lipolytic stimuli such as the beta-adrenergic pathway. A
number of proteins have been found embedded in the lipid droplet
membrane such as perilipin and adipophilin [30]. These proteins
are believed to be important in the coordination and recruitment
of lipases and other proteins to the lipid droplet. Lipid droplet com-
positional analysis in the human liver cell line HepG2 has revealed
that PC is themost abundant phospholipid present and that interest-
ingly the acyl chainsof thephospholipidarehighlyunsaturated [31].
This unique membrane lipid composition is likely to prove vital to
the functioning of the lipid droplet. Thus the ability and efﬁcient
accommodation of lipid storagewithin a lipid dropletmay be highly
dependent of the generation of MUFA. Unsaturated fatty acids (acyl
chainsC12-18 in length) butnot saturated fatty acids induce the for-
mation of lipid droplet or increase the size of pre-existing lipid drop-
lets [32]. Impairment in desaturase activity is correlated with a
decreased ability to generate lipid droplets and expansion of lipid
droplets to facilitate triglyceride storage [33]. Hence, a defect in
the fattyaciddesaturationprogrammemaycompromise theadipose
tissue capacity to store excess of dietary lipid inertly as triglyceride
within the lipid droplet, leading to the accumulation of toxic satu-
rated lipids within the cytoplasm.
In summary, the importance of maintaining an appropriate lipid
composition is stressed by the fact that a broad range of diseases
are associated with dysregulation of lipid metabolism and mem-
brane composition. The importance of maintaining tight control
of the lipid membrane characteristics requires that the cell mem-
branes have exquisite sensors able to detect subtle perturbations
coupled with effector mechanisms that actively maintain the opti-
mal membrane lipid composition. An important effector of this
allostatic response is SREBP, a transcription factor that regulatesunsaturated fatty acid biosynthesis (membrane ﬂuidizer) and cho-
lesterol biosynthesis (membrane rigidiﬁer). The fact that SREBP1 is
a strong regulator of desaturase activity (D-9, D-5 and D-6) and
that the transcription and activation of the SREBP1 protein is itself
regulated by the degree of saturation of lipids [34–36], along with
evidence produced via studies as discussed below, makes the
SREBP1 regulatory network an attractive candidate to be the mech-
anism of lipid membrane quality control.
7. SREBP: a lipid transcription factor that mediates the allostatic
response to maintain unsaturated lipid and cholesterol content
in cells
7.1. Structure of SREBPs
SREBPs belong to the basic helix loop helix leucine zipper
(bHLHLZ) family of transcription factors. SREBPs can bind to pro-
moter sequences containing sterol regulatory elements (SRE-50-
TCACNCCAC-30) and E-box sequences (50-CANNTG-30) .Three iso-
forms of SREBPs encoded by two genes have been identiﬁed SREB-
P1a and SREBP1c (also known as ADD1) are produced from a single
gene, srebf-1, whereas SREBP2 is produced from the gene srebf-2.
SREBP2 is approximately 50% identical to the SREBP1 isoforms.
SREBP1a and SREBP1c result from the use of two transcription start
sites that produce two separate 5-prime exons, each of which is
spliced to a common exon 2 [37]. SREBP1 and SREBP2 preferen-
tially regulate triglyceride and cholesterol biosynthesis, respec-
tively [5,38]. SREBPs are synthesised as ER precursor proteins
that require proteolytic cleavage to be transcriptionally active.
Immature precursor SREBPs are orientated in the ER membrane
in a hairpin conﬁguration with the carboxyl- and amino-terminus
facing towards the cytosol and are anchored in the ER as part of a
complex with SREBP cleavage activating protein (SCAP) and an ER
embedded protein Insig (insulin induced gene) until SREBP activa-
tion is required [37,38 and references within].
7.2. SREBP1 expression proﬁle
SREBP1a and SREBP1c differ in their tissue distribution. In gen-
eral SREBP1c is the predominant isoform in vivo, and is found in li-
ver, adrenal gland, adipose tissue, brain, kidney, muscle and
pancreas, with its highest expression being in liver and adipose tis-
sue [39]. SREBP1a is the predominant isoform in vitro and in pro-
liferative tissues such as spleen, testis and ileum. In terms of gene
expression the ratio between SREBP1c and SREBP1a in tissues var-
ies, with SREBP1c being nine- and three-fold higher than SREBP1a
in liver and adipose tissue, respectively [39]. As SREBP1a has high-
er transcriptional activity compared with SREBP1c, the baseline ra-
tio of SREBP1a and SREBP1c may be particularly important in
regulation of gene transcription.7.3. Regulation of SREBP cleavage
In response to stimuli to increase SREBP activity (e.g. low sterol
levels; saturated fatty acids), SCAP escorts SREBP1 from the ER to
the Golgi apparatus. SCAP/SREBP complex exits the ER via COPII
vesicles that bud from the ER membrane. Proteolytic cleavage of
SREBP1 occurs on the Golgi apparatus membrane by site-1-prote-
ase (S1P) and site-2-proteases (S2P) releasing the amino terminus
of SREBP1 (64kDa), which is able to enter the nucleus and trans-
criptionally up-regulate SREBP1 target genes [37]. Under condi-
tions where SREBP1 is to be repressed (e.g. high sterol levels;
unsaturated fatty acids) the retention of the SREBP–SCAP complex
is facilitated by Insig. SCAP contains a sterol-sensing domain (SSD).
Cholesterol has been shown to induce a conformational change in
2694 R.M. Hagen et al. / FEBS Letters 584 (2010) 2689–2698SCAP facilitating its binding to Insig [40], which prevents the trans-
location of the SREBP–SCAP complex from the ER and therefore
preventing up-regulation of SREBP1 target genes.
7.4. SREBP1 target genes
A promiscuous nature of SREBP1 is beginning to emerge with
SREBP1 regulating a diverse range of lipid and non-lipid pathways
illustrating that SREBP1 is not just involved in lipid biosynthesis
and accumulation. Recent studies, using bioinformatic tools have
identiﬁed 1141 promoters with putative binding sites for SREBP1
in HepG2 cells after insulin and glucose stimulation [41]. Overex-
pression of SREBP1 revealed signiﬁcant alteration in genes encod-
ing mitochondrial proteins and proteins involved in mitochondrial
respiration and oxidoreduction [42]. Thus these ﬁndings suggest
that SREBP1 may also modulate mitochondrial fatty acid oxidation.
SREBP1 is a fundamental regulator of fatty acid desaturation,
elongation and phospholipid biosynthesis, suggesting it could be
a key allostatic point of control of membrane lipid homeostasis
capable of strongly inﬂuencing the lipid composition of mem-
branes. As illustrated, the SREBP1/Insig allostatic network exerts
a great inﬂuence on the production of speciﬁc lipid species starting
either from de novo lipogenesis or from modulation of dietary lip-
ids. These lipid species can subsequently be incorporated into tri-
glycerides and phospholipids in a wide variety of possible
combinations (Fig. 2).
SREBP1 regulates a wide array of genes involved in lipid biosyn-
thesis, including genes involved in de novo lipogenesis (FAS, acetyl
co-A carboxylase (ACC1)), fatty acid reesteriﬁcation (diacylglycerol
acyltransferase (DGAT), Glycerol-3-phosphate acyltransferase
(GPAT), lipoprotein lipase (LPL)), fatty acid desaturation and elon-
gation [stearoyl Co-A desaturase (SCD), elongation of very longFig. 2. Fatty acids are numerically represented C:D, where C is the number of
carbon atoms present and D is the position of double bonds relative to the methyl
end of the fatty acid. SREBP1/Insig regulates synthesis of the major long chain fatty
acids that can be incorporated into triglycerides and phospholipids in any
combination at multiple points along the path.chain fatty acids (ELOVL)] and also phospholipid biosynthesis
(CCT). As regulation of these pathways is crucial for the metabolic
function of the cell, SREBP is an important central ﬁgure that must
be tightly controlled (Fig. 3).
Although it is obvious that a fundamental function of SREBP1 is
to regulate fatty acid biosynthesis and TAG storage; SREBP1 is also
involved in the regulation of non-lipid pathways. For instance,
SREBP1 upregulates the transcription and gene expression of
GIRK1/4 (a G protein coupled inward rectifying potassium channel)
in heart and sulfonylurea and potassium channels in the beta cells
of islets as a result of lipid lowering [43,44]. Therefore, this is a di-
rect evidence of how SREBP1 modulation affects physical proper-
ties of biomembranes inﬂuencing ion channel function. As well
as acting as a transcriptional activator SREBP can also act as an
inhibitor. SREBPs for example can impair insulin signalling in the
liver via inhibition of IRS-2 gene transcription, and thus may play
a crucial role in hepatic insulin sensitivity [45].
7.5. Transcriptional SREBP regulation
At transcriptional levels, promoter analysis of human and
mouse SREBP1 revealed the presence of SRE and RXR/LXR DNA
binding sites [38]. Glucose, insulin and liver X receptor (LXR)
upregulate the transcription of SREBP1c [38,43]. Activation of
SREBP1c stimulates its own promoter in an autoregulatory manner
and thus ampliﬁes the initial proteolytic signal [38]. Insulin in-
creases transcription, protein levels and proteolytic cleavage of
SREBP1 [43]. Action of insulin on SREBP1 is counteracted by gluca-
gon that inhibits SREBP activation via production of cAMP levels.
7.6. Posttranslational SREBP regulation
SREBPs are posttranslationally modiﬁed through various mech-
anisms including phosphorylation, sumoylation, ubiquitination
and acetylation. Lysine residues on nuclear SREBPs are ubiquitinat-
ed and degraded by the 26S proteosome [44]. Ubiquitination can
be blocked through the acetylation of lysine residues enhancing
the stability of SREBP1. Sumolyation represses transactivational
capacity of SREBP1a and SREBP2 [44]. SREBP1 is negatively regu-
lated by phosphorylation by GK3-beta and protein kinase A [44].
The phosphorylation status of SREBP1 appears to be important
during cell division as nuclear SREBP1a and SREBP1c are regulated
in mitotic cells by hyperphosphorylation [45]. It is hypothesised
that phosphorylation stabilises the SREBP protein and maintains
SREBP levels throughout cell division.
The addition of excess cholesterol inhibits both SREBP1 and
SREBP2proteolytic cleavage invitroand invivo [39].However, phys-
iologically the posttranslational regulation of SREBPs appears to be
isoform speciﬁc, as in vivo studies suggest that whilst sterol deple-
tion activates SREBP2 cleavage, sterol depletion does not regulate
SREBP1 cleavage [40,46], suggesting that SREBP1 may not be regu-
latedbycholesterol.Also, stimulationof SREBP1ccleavageby insulin
occurs in the absence of variations in sterol [46]. These suggest that
SREBP1c maturation under physiological conditions is predomi-
nantly regulated in response tonutritional status rather thanbycho-
lesterol. In fact changes in nutritional status have been shown to be
important in SREBP1 regulation in adipose tissue and liver [43].
SREBP1 nuclear protein levels are increased in liver in response to
a high fat diet (HFD) and a fasting/refeeding protocol whereas
SREBP2 is not. Its physiological relevance is conﬁrmed as induction
of lipogenesis by HFD is prevented in SREBP1c KO mice [38].
7.7. Fatty acid regulation of SREBP
In vitro and in vivo studies have shown that SREBP1 regulation
is mediated by fatty acids in animal cells. Transcription and
Fig. 3. SREBP1 is a central node linked to a wide variety of genes and thus has the capacity to inﬂuence many pathways. SREBP1 activity/inhibition is regulated depending on
the environmental demands of the cells. ACC, acetyl-CoA carboxylase; ACS, acyl-CoA synthetase; CCT, CTP:phosphocholine cytidylyltransferase; CD36/FAT, fatty acid
translocase; ELOVL, elongation of very long chain fatty acids; FAS, fatty acid synthase; HSL, hormone sensitive lipase; Insig, Insulin-induced gene; LPL, lipoprotein lipase; ME,
malic enzyme; mtGPAT, mitochondrial glycerol-3-phosphate acyltransferase; SREBP1, sterol regulatory element binding protein; TAG, triacylglycerol.
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[34–36]. In contrast, human and mouse cultured cells grown in
medium lacking unsaturated FA have increased activation of SREB-
P1a and SREBP1c [34–36]. The potency of inhibition by unsatu-
rated fatty acids increases with chain length and the degree of
unsaturation in cultured human embryonic kidney (HEK)-293 cells
[34]. The effect of MUFA and PUFAs on SREBP1 transcription may
be mediated through blockage of ligand dependent activation of
LXR. In addition, the PUFA, arachidonic fatty acid has been shown
to prevent SREBP processing by stabilising Insig-1 via blockage of
ubiquitination sites on Insig-1 in a Chinese hamster cell line [47].
Sterols are able to prevent the degradation of Inisg-1 by inducing
a conformational change that blocks the Insig-1 ubiquitination
sites. Unsaturated fatty acids delay the degradation of Insig-1 by
preventing the extraction of the ubiquitinated Inbsig-1 from the
ER membrane. This extraction process is mediated by valosin-con-
taining protein and Ubxd8 protein. Unsaturated fatty acids prevent
the interaction between Ubxd8 and Insig-1 [47]. Whether satu-
rated fatty acids also exert an effect on SREBP activation via Insig
regulation requires further examination. As aforementioned,
SREBPs are known to regulate desaturase gene expression
[48,49]. Therefore, fatty acids appear to regulate SREBP1 activation
in a feedback loop, controlling the ratio of unsaturated and satu-
rated fatty acids.
Another interesting aspect of SREBP1 regulation comes from the
studies performed in drosophila. The bHLHLZ domain of SREBP1,
including the tyrosine residue in the basic domain is evolutionary
conserved. Interestingly, there is an ortholog of SREBP and SCAP
present in drosophila (dSREBP). SREBP proteolytic cleavage by SIPand S2P occurs in drosophila similar to mammals, despite drosoph-
ila being unable to synthesise sterols. In fact, in this model, it is the
phospholipid phospatidylethanolamine (PE), which coordinates
regulation over SREBP activity [50,51]. In this model increased PE
content decreases SREBP activity. The SSD of the SCAP protein is
thus sensitive to alterations in PE rather than exclusively to sterols
Whether this property of the sterol-sensing domain has been con-
served in higher animal organisms is unknown at present and it is
an important aspect that may reveal the primary fundamental role
of SREBP. The insertion of cholesterol and PE into the membrane
exerts similar phase transitions in the membrane as both are cone
shaped and promote the transition of lipid bilayers to an inverted
hexagonal phase. This suggests that the SSD of SCAP is capable of
responding to the physical properties (membrane thickness or ﬂu-
idity) or phase transitions of the membranes rather than just sterol
content [51]. As the SSD of dSCAP shares approximately 47% amino
acid sequence identity with human SSD of SCAP, it may be the case
that human SCAP monitors lipid composition responding to
changes in the physical state of the membrane rather than sterol
content alone. This places the SREBP network as a possible lipid
sensor/effector network able to respond and activate appropriate
lipid biosynthetic pathways when optimal lipid composition/phys-
ical properties of membranes are compromised.
8. SREBP network as allostatic mediators of lipid membrane
composition
It has been demonstrated that activation of SREBP1 and SREBP2
occurs in response to general membrane demand as well as by
Fig. 4. SREBP1 conservation through organisms – amino acid sequences of basic helix loop helix leucine zipper were aligned using NCBIs HomoloGene database (http://
www.ncbi.nlm.nih.gov/homologene). Conserved tyrosine residue is highlighted in bold. Gene reference sequences are NP_001005291.1 (Homo sapiens, XP_864642.1 (Canis
lupus familiaris), XP_001790652.1 (Bos Taurus), NP_035610.1 (Mus musculus), XP_213329.4 (Rattus norvgicas), NP_001098599.1 (Danio rerio), NP_730450.1 (Drosophila
melanogaster), XP_311076.4 (C. elegans).
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cytosis: In human HEK-293 cell line, phagocytosis stimulates the
proteolytic cleavage of SREBP and enhances transcription of lipo-
genic genes. Blockage of SREBP inhibits phagocytosis induced tran-
scription and cholesterol and phospholipid biosynthesis. This
suggests that SREBPs are activated to generate lipid species to be
incorporated into the growing membrane [53]. It appears that
the SREBP/Insig regulation is crucial in generating unsaturated li-
pid species in particular to be incorporated into the membrane.
The relevance of SREBP/Insig regulation in generating unsaturated
lipid species through desaturase regulation has been demon-
strated. For example, the overexpression of SREBP1a results in an
enrichment (15–20%) of oleate content in liver [54] due to in-
creased elongase and desaturase gene expression. In addition, the
relevance of SCD1 and MUFA generation in altering the membrane
organisation has been demonstrated in hepatocytes of SCD1
knockout mice. A lack of SCD1 in mice results in an activation of
CCT and PC [55] biosynthesis. The reduction in MUFA content in
hepatic phospholipds may result in an increased membrane afﬁn-
ity for CCT thus increasing its translocation and activation. The
upregulation of SREBP1 during phagocytosis results in the upregu-
lation of unsaturated fatty acid biosynthesis and redistribution of
cholesterol. In addition, cells grown in medium lacking unsatu-
rated FA have increased activation of SREBP1a and SREBP1c [34].
SREBP1s are relatively well conserved across different species
(from ﬁssion yeast up to humans) (Fig. 4). The C. elegans SREBP
homolog Sp1 increases unsaturated fatty acid biosynthesis. Reduc-
tion of Sp1 using RNA interference in C. elegans results in impaired
intestinal fat storage, a high saturated fatty acid content, a reduc-
tion in D-9 desaturase activity, infertility, decreased growth and
slow location, suggesting that SREBP is crucial for unsaturation in
C. elegans. The defects of Sp1 deﬁcient worms could be rescued
by dietary addition of oleic acid [56].
In conclusion, these studies indicate that the primary function
of SREBP1 may be to coordinate the transcription of membrane
biogenesis and in particular, regulating the production of unsatu-
rated fatty acids to maintain optimal membrane composition in re-
sponse to environmental demands.
9. Concluding remarks
Allostatic programmes are important mechanisms facilitating
an adaptive response to maintain physiological normality in re-
sponse to stress conditions to ensure the survival of the species.
Allostatic responses may also be responsible for the strict regula-
tion of biological membrane composition. As detailed earlier mem-
brane ﬂuidity is important in regulating a wide range of biological
functions, therefore membrane composition is tightly regulated to
maintain cellular viability. Relatively small changes in the concen-
tration of membrane lipids in the order of 10% are signiﬁcant en-ough to alter biophysical properties of the membrane [57]. A
reduction in temperature results in decreased membrane ﬂuidity
and as a consequence unsaturated fatty acid production through
the fatty acid desaturation pathway is increased, thus maintaining
the biological membrane in a ﬂuid state. This dynamic allostatic re-
sponse to perturbations results in robust networks that can re-
spond to external and internal stimuli whilst maintaining normal
cell function. We postulate that the allostatic adaptation of
SREBP1/Insig-1 is sensitive to the degree of fatty acid desaturation
occurring within the cell and is likely to be present to maintain the
production of unsaturated fatty acids and prevent saturated fatty
acid accumulation within the cytosol that can compromise cell
function through cell signalling and alterations in the membrane
composition.
10. Future studies
Future studies will be needed to further investigate whether the
SREBP1/Insig1 network is indeed acting as a lipid membrane qual-
ity control mechanism. Particularly relevant to adipose tissue,
SREBP1 activation may be crucial in providing unsaturated lipid
species as important components of the lipid droplet. Data from
the literature suggests a correlation between the supply of MUFA
and lipid droplet size. The ability to expand lipid droplets to
accommodate and store excess fatty acids is an important process
to inertly store away fatty acids. The channelling of excess satu-
rated FA to triglyceride stores is likely an adaptive mechanism
against the accumulation of cytosolic fatty acids and ﬂux of excess
fatty acids towards peripheral insulin sensitive tissues and protec-
tive against lipotoxicity. Therefore, the extent to which the lipid
droplet and adipose tissue can expand to accommodate fatty acid
inﬂux will determine the extent of the pathological state. In the ad-
vent of adipose tissue being no longer able to store excess lipid
effectively, excess lipids are diverted to peripheral tissues and have
a lipotoxic effect.
In addition, future studies investigating the function of SREBP1
should not be limited to the traditional lipid storage organs such as
adipose tissue and liver. Many cell-types contain lipid droplets that
store neutral lipids for metabolism, membrane synthesis (phos-
pholipids and cholesterol) and steroid synthesis. Indeed, SREBP1c
is found in a variety of tissues, such as brain, skeletal muscle, heart,
kidney, pancreas and brown adipose tissue. It may be that SREBPs
primary function is to ensure that the appropriate unsaturated
fatty acids for phospholipids synthesis are present. Inappropriate
accumulation of saturated fatty acids can compromise cell
membrane ﬂuidity and function, and in order to maintain an opti-
mum ratio of unsaturated to saturated fatty acids, particularly in
biological membrane, SREBPs are activated and upregulate target
genes involved in desaturation of fatty acids and phospholipid
synthesis.
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